SCHH vs XBI
Schwab US REIT ETF vs SPDR S&P Biotech ETF
SCHH$23.44
Schwab US REIT ETF
US REITs at very low cost.
Expense: 0.07%Yield: 2.78%
XBI$133.66
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.34%
Quick take
- • SCHH has the lower expense ratio at 0.07% vs 0.35% for XBI.
- • SCHH pays a higher dividend yield (2.78%).
Side-by-side metrics
| Metric | SCHH | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.07% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.78% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $9.93B | $8.30B |
YTD return | 13.68% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.05 | 1.09 |
P/E ratio | 30.73 | — |
Last price | $23.44 | $133.66 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHH top holdings
Top holdings · SCHH
| WELL | Welltower Inc | 10.09% |
| PLD | Prologis Inc | 8.80% |
| EQIX | Equinix Inc | 5.06% |
| DLR | Digital Realty Trust Inc | 4.52% |
| SPG | Simon Property Group Inc | 4.43% |
| AMT | American Tower Corp | 4.20% |
| O | Realty Income Corp | 4.19% |
| PSA | Public Storage | 3.34% |
| VTR | Ventas Inc | 2.99% |
| CCI | Crown Castle Inc | 2.69% |
Sector breakdown · SCHH
Real Estate100.0%
XBI top holdings
Top holdings · XBI
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
Sector breakdown · XBI
Financial Services0.2%
Healthcare99.8%
About SCHH
SCHH (Schwab US REIT ETF) is US REITs at very low cost. Managed by Schwab, the fund carries $9.9B in assets under management, an expense ratio of 0.07%, a dividend yield of 2.78%. Its largest holding is Welltower Inc (WELL), which represents 10.1% of the portfolio. Real Estate is the fund's largest sector exposure at 100.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.